Anti-SYK/ KARS/ CMTRIB monoclonal antibody

Anti-SYK/ KARS/ CMTRIB antibody for FACS & in-vivo assay

Target products collectionGo to KARS/KARS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2574-Ab-1/ GM-Tg-hg-MP2574-Ab-2Anti-Human KARS monoclonal antibodyHuman
GM-Tg-rg-MP2574-Ab-1/ GM-Tg-rg-MP2574-Ab-2Anti-Rat KARS monoclonal antibodyRat
GM-Tg-mg-MP2574-Ab-1/ GM-Tg-mg-MP2574-Ab-2Anti-Mouse KARS monoclonal antibodyMouse
GM-Tg-cynog-MP2574-Ab-1/ GM-Tg-cynog-MP2574-Ab-2Anti-Cynomolgus/ Rhesus macaque KARS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2574-Ab-1/ GM-Tg-felg-MP2574-Ab-2Anti-Feline KARS monoclonal antibodyFeline
GM-Tg-cang-MP2574-Ab-1/ GM-Tg-cang-MP2574-Ab-2Anti-Canine KARS monoclonal antibodyCanine
GM-Tg-bovg-MP2574-Ab-1/ GM-Tg-bovg-MP2574-Ab-2Anti-Bovine KARS monoclonal antibodyBovine
GM-Tg-equg-MP2574-Ab-1/ GM-Tg-equg-MP2574-Ab-2Anti-Equine KARS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2574-Ab-1/ GM-Tg-hg-MP2574-Ab-2; GM-Tg-rg-MP2574-Ab-1/ GM-Tg-rg-MP2574-Ab-2;
GM-Tg-mg-MP2574-Ab-1/ GM-Tg-mg-MP2574-Ab-2; GM-Tg-cynog-MP2574-Ab-1/ GM-Tg-cynog-MP2574-Ab-2;
GM-Tg-felg-MP2574-Ab-1/ GM-Tg-felg-MP2574-Ab-2; GM-Tg-cang-MP2574-Ab-1/ GM-Tg-cang-MP2574-Ab-2;
GM-Tg-bovg-MP2574-Ab-1/ GM-Tg-bovg-MP2574-Ab-2; GM-Tg-equg-MP2574-Ab-1/ GM-Tg-equg-MP2574-Ab-2
Products NameAnti-KARS monoclonal antibody
Formatmab
Target NameKARS
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KARS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SYK/ KARS/ CMTRIB VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP005103human KARS Lentivirus plasmid
    ORF Viral VectorvGMLP005103human KARS Lentivirus particle


    Target information

    Target IDGM-MP2574
    Target NameKARS
    Gene ID3735,85305,292028,714516,479644,101092570,509624,100055335
    Gene Symbol and SynonymsCMTRIB,D8Ertd698e,D8Wsu108e,DEAPLE,DFNB89,KARS,KARS1,KARS2,KRS,LEPID,LysRS,mKIAA0070
    Uniprot AccessionQ15046,Q5XIM7
    Uniprot Entry NameSYK_HUMAN,SYK_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000065427
    Target ClassificationN/A

    The target: KARS, gene name: KARS, also named as CMTRIB, DFNB891, KARS2, KRS, KARS. Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. Lysyl-tRNA synthetase is a homodimer localized to the cytoplasm which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.